EMA workshop on primary efficacy endpoints for antivirals and mAbs intended for the treatment of COVID-19 and Influenza, ...
The workshop is organised to bring together academic, regulatory, industry and healthcare professionals. The workshop will discuss aspects on similarities and major challenges experienced with the clinical study design in antiviral treatment trials for …